BlueRock Therapeutics receives FDA Regenerative Medicine Advanced Therapy designation for Parkinson’s disease cell therapy candidate bemdaneprocel
GlobeNewswire
•Regenerative Medicine Advanced Therapy (RMAT) designation follows phase I clinical trial results demonstrating that..